螺内酯治疗后肾素反应性的长期改变。低肾素性高血压假阴性检测的一个原因。 - Suppr | 超能文献

Prolonged alteration of renin responsiveness after spironolactone therapy. A cause of false-negative testing for low-renin hypertension.

作者信息

Lowder S C, Liddle G W

出版信息

N Engl J Med. 1974 Dec 5;291(23):1243-4. doi: 10.1056/NEJM197412052912309.

DOI:10.1056/NEJM197412052912309

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Prolonged alteration of renin responsiveness after spironolactone therapy. A cause of false-negative testing for low-renin hypertension.螺内酯治疗后肾素反应性的长期改变。低肾素性高血压假阴性检测的一个原因。

N Engl J Med. 1974 Dec 5;291(23):1243-4. doi: 10.1056/NEJM197412052912309.

2

Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.血压及肾素-血管紧张素-醛固酮轴对降压治疗的反应：普萘洛尔与螺内酯的比较

N Z Med J. 1977 Sep 14;86(595):216-9.

3

[Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)].原发性高血压且血浆肾素水平低的患者中可交换钠、总体钾、血浆容量及各种利尿剂的降压作用（作者译）

Dtsch Med Wochenschr. 1974 Apr 26;99(17):864-9. doi: 10.1055/s-0028-1107855.

4

Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.氯噻酮与螺内酯治疗低肾素性原发性高血压的比较。

Can Med Assoc J. 1983 Jan 1;128(1):31-4.

5

[Relations between hypotensive effect and modifications of volemia and plasma renin activity in patients with essential hypertension treated using spironolactone].[原发性高血压患者使用螺内酯治疗时降压效果与血容量及血浆肾素活性变化之间的关系]

Minerva Med. 1977 Feb 18;68(8):509-14.

6

[The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man].

Orv Hetil. 1972 Jan 2;113(1):23-4.

7

[Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].[原发性高血压患者使用利尿剂治疗期间血压、血容量与血浆肾素之间的相关性。盐皮质激素拮抗剂螺内酯与“袢”利尿剂美夫西特的比较]

Schweiz Med Wochenschr. 1977 Jan 29;107(4):104-15.

8

The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.螺内酯、氨氯吡咪、氯沙坦与噻嗪类药物（SALT）对低肾素性高血压和醛固酮-肾素比值升高患者的双盲交叉试验。

Circulation. 2007 Jul 17;116(3):268-75. doi: 10.1161/CIRCULATIONAHA.107.690396. Epub 2007 Jul 2.

9

Diuretic therapies in low renin and normal renin essential hypertension.低肾素和正常肾素原发性高血压的利尿疗法

Clin Pharmacol Ther. 1977 Jul;22(1):14-20. doi: 10.1002/cpt197722114.

10

Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.血浆肾素活性受抑制的原发性高血压研究：限盐时的钠排泄模式及螺内酯对血压和血浆肾素活性的影响

Jpn Circ J. 1972 Dec;36(12):1301-11. doi: 10.1253/jcj.36.1301.

引用本文的文献

1

Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis.盐皮质激素阻断剂的药代动力学和药效学及其对钾稳态的影响。

Heart Fail Rev. 2005 Jan;10(1):23-9. doi: 10.1007/s10741-005-2345-1.

2

The renin/angiotensin system.肾素-血管紧张素系统

Br J Clin Pharmacol. 1981 Nov;12(5):605-12. doi: 10.1111/j.1365-2125.1981.tb01278.x.

3

Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.低肾素性原发性高血压患者肾上腺对血管紧张素II的敏感性增加。

J Clin Invest. 1978 Jun;61(6):1456-62. doi: 10.1172/JCI109065.